Clinical Trials · NCT06363747

The Medically Reproducing Bariatric Surgery (MRB) II Study

Active Not RecruitingPhase 2/Phase 3Semaglutide (Investigational)
Phase
Phase 2/Phase 3
Recruitment status
Active Not Recruiting
Sponsor
Durham VA Medical Center
Enrollment
50
Start date
Jun 2024
Locations
1 site, United States
Primary endpoint
Glycemic Control
View Semaglutide compound reference